Evidence map›Paper›PMID 42446756›Full record

ArticleBiotechnology letters2026

High-yield RNA extraction from Nepenthes × ventrata pitchers by simple modification of the CTAB method.

Kaho Teramachi, Tsuyoshi Kaneta

Abstract read
PubMed Publisher
In one paragraph

Article in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kaho TeramachiGraduate School of Science & Engineering, Ehime University, Matsuyama, 790-8577, Japan.
Tsuyoshi KanetaGraduate School of Science & Engineering, Ehime University, Matsuyama, 790-8577, Japan. kaneta.tsuyoshi.mm@ehime-u.ac.jp.ORCID https://orcid.org/0000-0001-8935-4443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA extraction from some plants is difficult owing to the presence of pigments and secondary metabolites in vacuoles and cell walls, which hinder molecular biological studies. In this study, we developed a simple method for high-yield RNA extraction from pitchers of the carnivorous plant Nepenthes × ventrata that is recalcitrant to RNA isolation. RNA was extracted from pitchers of Nepenthes × ventrata at different developmental stages using conventional methods. Additionally, a modified cetyltrimethylammonium bromide (CTAB) method, in which an ethanol-precipitation step at high LiCl concentration was introduced, was used to extract RNA. Conventional purification methods yielded low or negligible amounts of RNA from pitcher tissues of Nepenthes, and the extracts contained visible pigment contamination. The conventional CTAB method, which is effective for RNA extraction from sweet potato tissues, also yielded only a small amount of RNA from Nepenthes tissues; most of the RNA remained in the supernatant discarded during the LiCl precipitation step, along with the contaminating pigments. By replacing this step with ethanol precipitation in the presence of high concentration of LiCl, the contaminating pigments were removed, and RNA with high purity and yield was recovered. Purified RNA could be efficiently used for full-length cDNA synthesis. The modified method requires no expensive extraction kits and is relatively safe because it does not use phenol. Therefore, this method may be effectively applied to plants that are recalcitrant to RNA isolation.

Indexed as

CetrimoniumCetrimonium CompoundsRNA, PlantEthanolCetrimoniumCetrimonium CompoundsEthanolRNA, PlantCetyltrimethylammonium bromide methodNepenthesRecalcitrant plantsRNA extraction

Identifiers

PMID42446756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.